Want Steady Dividend Income? Invest in These 3 Dividend Kings With 64 Years of Raises
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Three Dividend Kings are paying shareholders in December, and the first deadline to qualify arrives next week. Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) goes ex-dividend on Nov. 24. Coca-Cola (NYSE:KO) and McDonald’s (NYSE:MCD) follow a week later. Each of the three covers its payout with recurring cash flow, investment-grade discipline and decades of annual raises, so the December check is one of the most reliable an income portfolio can collect.
You have to own the shares before the ex-dividend date. Under next-day settlement, the ex-dividend date and the record date now fall on the same day, which makes the last trading session before the ex-date your real deadline. Markets also close for Thanksgiving, so the buying windows are shorter than the calendar suggests.
| Stock | Quarterly Dividend | Ex-Dividend Date | Last Day to Own Shares | Pay Date |
|---|---|---|---|---|
| Johnson & Johnson | $1.34 | Nov. 24 | Mon., Nov. 23 | Dec. 8 |
| Coca-Cola | $0.53 | Dec. 1 | Mon., Nov. 30 | Dec. 15 |
| McDonald’s | $1.93 | Dec. 1 | Mon., Nov. 30 (Fri., Nov. 27 to be safe) | Dec. 15 |
Johnson & Johnson: First Cutoff and the Lowest Payout Ratio
Johnson & Johnson pays $1.34 per share on Dec. 8 to holders of record on Nov. 24. The last day to own shares is Monday, Nov. 23. The trailing yield is 1.85%, and the $5.36 annualized forward dividend works out to about 1.93% at the current $275.29 share price.
Dividend safety: This is the best-covered payout of the three. The board raised the quarterly dividend 3.1% to $1.34[1], which the company said marks its 64th consecutive year of increases. The payout history confirms the climb, rising from $1.24 to $1.30 to the current rate. Against the low end of now-dated Q2 adjusted EPS guidance of $11.60–$11.75[2], the forward dividend used about 46% of earnings. Second-quarter net income came in at $5.534 billion. Q1 free cash flow of $1.5B[1] was held down by timing. The balance sheet carries a AAA credit rating, a distinction few U.S. companies hold.
Bull case: Growth is accelerating into the dividend. Second-quarter revenue rose 6.6% to $25.31B[2], adjusted EPS of $2.90 exceeded the $2.85 consensus, and Innovative Medicine grew 7.8%. Back then, management raised its now-dated revenue guidance to $100.8B–$101.4B[2], with CEO Joaquin Duato pointing to “quarterly sales surpassing $25 billion”. The pipeline keeps getting richer: J&J just agreed to acquire Ollin Biosciences. Shares are up 32.77% year to date and trade at a forward P/E of 24x. That rally has compressed the yield, but the growing earnings base makes each future raise easy to fund.
Risk: STELARA sales fell 55.2% year over year in Q2 as biosimilars took share. If newer drugs stop outpacing that erosion, earnings growth slows and future raises will likely stay in the low single digits.
Coca-Cola: Raised Cash Flow Guidance Funds the Next Raise
Coca-Cola pays $0.53 per share on Dec. 15, with an ex-dividend and record date of Dec. 1. Your last day to own shares is Monday, Nov. 30. The trailing yield stands at 2.07%, and the $2.12 forward annual rate yields about 2.17% at a share price around $97.71.
Dividend safety: The latest increase, from 51 cents to 53 cents, extended Coca-Cola’s streak to 64 years in a row. The payout record shows a step up every year, from 40 cents in 2019 to today’s rate. The forward dividend equals roughly 63% of trailing EPS of $3.39. At the forward rate, the annual dividend bill runs about $9.12 billion. Management now guides to free cash flow of at least $13 billion, up from $12.4 billion, which covers the dividend with roughly 70% of forecast cash flow paid out. Leverage is manageable at 2.49x net debt to EBITDA, and interest coverage is 8.32.
Bull case: Momentum is building. Q3 revenue rose 7.43% to $13.38 billion, adjusted EPS of 91 cents came in ahead of the 88-cent consensus, and global unit case volume grew 5%, led by Coca-Cola Zero Sugar at 16%. The comparable operating margin expanded to 32.9%[3], and full-year guidance now calls for comparable EPS growth of at least 11%. Earnings growth at that pace funds raises well above the low-single-digit increases income investors have come to expect from Coca-Cola. Shares trade at 32x trailing earnings after a 41.36% year-to-date run, close to the $100.56 52-week high.
Risk: Bottling divestitures, including the pending African sale, create an approximately 8% revenue drag next year. Reported growth will look weaker, and if margin gains fail to offset it, the stock’s premium multiple has room to contract.
McDonald’s: Newest Dividend King, Biggest Yield of the Three
McDonald’s pays its newly raised $1.93 per share on Dec. 15. Two market data feeds list Dec. 1 as the ex-dividend date and Dec. 1 as the record date, which makes Monday, Nov. 30, the last day to own shares. One listing shows an ex-date of Nov. 30, so the safest cutoff is the close on Friday, Nov. 27. The trailing yield is 2.63%, and the new $7.72 annualized rate yields about 2.81% at $273.26 per share, the highest forward yield in this group.
Dividend safety: The 4% increase to $1.93 marked McDonald’s 50th consecutive annual dividend increase, officially moving it into Dividend King territory. The payout record backs that up, stepping from $1.52 in 2023 to $1.67, $1.77, $1.86 and now $1.93. The forward dividend takes up about 61% of trailing EPS of $12.64, and the dividend yield equals roughly 71% of the 3.69% free cash flow yield. Leverage is the highest of the three at 3.70x net debt to EBITDA, but interest coverage of 7.83 and franchise royalties make the debt load predictable. Negative book equity reflects years of buybacks, a common feature of mature capital payers.
Bull case: This is the one Dividend King on the list that the market has marked down. Shares are off 9.89% year to date and trade at 20x forward earnings, while the business keeps compounding. Q3 adjusted EPS of $3.57 exceeded the $3.38 consensus, operating income rose 7.09%, and systemwide sales grew 4% to over $38 billion. A 46.1% operating margin built on franchise fees keeps cash flowing even when traffic moderates. CEO Chris Kempczinski said, “In the U.S., we’re encouraged by improvement as the quarter progressed following our intervention on value.” If that U.S. improvement holds, the group’s highest yield comes with room for the multiple to recover.
Risk: U.S. comparable sales slipped 0.2% on weak guest counts. If value promotions fail to bring traffic covers, earnings growth stalls and future raises shrink toward the low single digits.
3 December Checks, 3 Different Safety Profiles
Johnson & Johnson offers the richer coverage and a AAA balance sheet, Coca-Cola pairs a 64-year streak with rising cash flow guidance and McDonald’s brings the highest forward yield after a year-to-date share price decline. All three fund their dividends comfortably from earnings and cash flow, which is what keeps a Dividend King streak alive. The calendar is the only variable left: Nov. 23 for J&J, and Nov. 30 for Coca-Cola and McDonald’s.
Contact [email protected] for any questions or corrections.








